JP2013535251A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535251A5
JP2013535251A5 JP2013519923A JP2013519923A JP2013535251A5 JP 2013535251 A5 JP2013535251 A5 JP 2013535251A5 JP 2013519923 A JP2013519923 A JP 2013519923A JP 2013519923 A JP2013519923 A JP 2013519923A JP 2013535251 A5 JP2013535251 A5 JP 2013535251A5
Authority
JP
Japan
Prior art keywords
medical gel
medical
present
weight
gel according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013519923A
Other languages
English (en)
Japanese (ja)
Other versions
JP5881698B2 (ja
JP2013535251A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2011/000829 external-priority patent/WO2012009794A1/en
Publication of JP2013535251A publication Critical patent/JP2013535251A/ja
Publication of JP2013535251A5 publication Critical patent/JP2013535251A5/ja
Application granted granted Critical
Publication of JP5881698B2 publication Critical patent/JP5881698B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013519923A 2010-07-19 2011-07-18 エーテルヒドロキシエチルセルロースを含む抗微生物医療用ジェル Expired - Fee Related JP5881698B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36544410P 2010-07-19 2010-07-19
US61/365,444 2010-07-19
PCT/CA2011/000829 WO2012009794A1 (en) 2010-07-19 2011-07-18 Antimicrobial medical gel composition comprising etherified hydroxyethylcellulose

Publications (3)

Publication Number Publication Date
JP2013535251A JP2013535251A (ja) 2013-09-12
JP2013535251A5 true JP2013535251A5 (https=) 2014-09-04
JP5881698B2 JP5881698B2 (ja) 2016-03-09

Family

ID=45496403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013519923A Expired - Fee Related JP5881698B2 (ja) 2010-07-19 2011-07-18 エーテルヒドロキシエチルセルロースを含む抗微生物医療用ジェル

Country Status (8)

Country Link
US (1) US8618175B2 (https=)
EP (1) EP2595480B1 (https=)
JP (1) JP5881698B2 (https=)
AU (1) AU2011282427B8 (https=)
BR (1) BR112013000759A2 (https=)
CA (1) CA2802356C (https=)
WO (1) WO2012009794A1 (https=)
ZA (1) ZA201209317B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120150033A1 (en) * 2010-12-13 2012-06-14 Loren Curtis Rauch Antimicrobial ultrasound transmission gel
CN103432600B (zh) * 2013-08-26 2015-01-28 王春红 一种抗菌型医用超声耦合剂及其制备方法
CN107530050A (zh) * 2015-05-20 2018-01-02 富士胶片株式会社 超声波诊断用涂布型接触介质
EP3400026A4 (en) * 2016-01-10 2019-08-14 Smilesonica Inc. VISCOSITY AND STABILITY-MODIFIED ULTRASOUND GEL
US20190262279A1 (en) * 2016-07-01 2019-08-29 Tissue Tools Llc Water-based emollient compositions and methods of use therefor
US9895453B1 (en) 2016-08-04 2018-02-20 Mark Edward Fenzl Shiny ultrasound gel
US10646597B2 (en) 2016-10-19 2020-05-12 Wiesman Holdings, LLC Coupling agent produced from naturally fermented and sustainable additives
CN116472311A (zh) * 2020-11-04 2023-07-21 赫尔穆特·哈斯 接触介质
WO2024215540A1 (en) * 2023-04-11 2024-10-17 Avava, Inc. Interface medium for dermatological laser treatments

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020061864A1 (en) 1994-09-22 2002-05-23 Geda International Marketing Company Ltd. Antiseptic spermicidal composition and means for its application
DE19639816A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
FR2770402A1 (fr) 1997-11-05 1999-05-07 Pierre Cohen Gel de conduction ultrasonore pour echographie, doppler et examens electrocardiographiques presentant des proprietes antiseptiques
JP2002087935A (ja) * 2000-09-07 2002-03-27 Kao Corp 皮膚外用剤
DE10348680A1 (de) * 2003-10-15 2005-05-12 Hans Schwarzkopf & Henkel Gmbh Mittel enthaltend Baldrian
ES2331195T3 (es) 2004-07-15 2009-12-23 Gynaecologiq B.V. Composicion y metodo para imagineria medica de cavidades corporales.
WO2007038855A1 (en) * 2005-10-04 2007-04-12 Sigmacon Medical Products Corporation Medical gel
US20080260864A1 (en) * 2005-10-21 2008-10-23 Medidermis Ltd. Topical Compositions for the Treatment of Depilation-Induced Irritation or Prevention Thereof
EP1991688B1 (en) * 2006-02-10 2019-05-01 DuPont Tate & Lyle Bio Products Company, LLC Biodegradable compositions comprising renewably-based, biodegradable 1.3-propanediol
EP2032115B1 (en) * 2006-06-16 2021-07-21 DSM IP Assets B.V. Compositions based on hyperbranched condensation polymers and novel hyperbranched condensation polymers
US20110092449A1 (en) * 2007-12-21 2011-04-21 Bradford James Duft Treatment of fibrotic conditions

Similar Documents

Publication Publication Date Title
JP2013535251A5 (https=)
JP2016520558A5 (https=)
JP2018021007A5 (https=)
JP2016505044A5 (https=)
JP2011105738A5 (https=)
JP2017509718A5 (https=)
EP3650012A4 (en) SOLID COMPOSITION CONSISTING OF AN AGENT OF IODINE AND SODIUM CHLORIDE HAVING AN IMPROVED SOLUBILITY IN WATER, AND ANTIVIRAL AND ANTIMICROBIAL COMPOSITION FOR IL, ORAL CAVITY, NASAL CAVITY OR INHALATION CONTAINING AN AQUEOUS SOLUTION OF THE SAME- THIS
JP2014525972A5 (https=)
JP2014139241A5 (https=)
JP2015057437A5 (https=)
AR074423A1 (es) Suspension farmaceutica que incluye polietilenglicol de alto peso molecular
JP2013209371A5 (https=)
JP2013177401A5 (https=)
CN115667278A (zh) 乏氧活化的dna烷化剂及其医药用途
JP2014503607A5 (https=)
AU2011282427A8 (en) Antimicrobial medical gel composition comprising etherified hydroxyethylcellulose
JP2007526383A5 (https=)
PH12014502743A1 (en) Carbamate/urea derivatives
JP2022511335A5 (https=)
JP2019151627A5 (https=)
JP2019104727A5 (https=)
CL2015003787A1 (es) Compuestos para la formación de pro-drogas
JP2016069467A5 (https=)
EP2486914A3 (en) Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2015051045A3 (en) 3'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE